PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50121C00073Eo14042 LETTER contract ADD FAR 52.223-99 — Elusys Therapeutics, Inc

Elusys Therapeutics, Inc holds $123.6M across 5 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Sep 14, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Barda - Aspr / Daappo / Barda Dcma
Awarding office
Elusys Therapeutics, Inc
Recipient
Sep 14, 2024
PoP end
$30M
Obligated
325412
NAICS
6505
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Elusys Therapeutics, Inc — $90

Contract facts

NONE
Contract number75A50121C00073
AgencyBarda - Aspr / Daappo / Barda Dcma
Awarding officeBarda - Aspr / Daappo / Barda Dcma
IncumbentElusys Therapeutics, Inc
UEIELP1DCK8L191
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Place of performancePARSIPPANY, NJ
Related solicitation6/28/2021
PoP end (current)Sep 14, 2024
Obligated$30M

EO14042 LETTER CONTRACT ADD FAR 52.223-99 ENSURING ADEQUATE COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS (OCT 2021… is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Elusys Therapeutics, Inc. Estimated value $80.9M ($30M obligated). Current period of performance ends Sep 14, 2024. Last award drew 1 bidder. Place of performance: PARSIPPANY, NJ. Related solicitation 6/28/2021.

EO14042 LETTER CONTRACT ADD FAR 52.223-99 ENSURING ADEQUATE COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS (OCT 2021)(DEVIATION)

Recompete timing

Public
Past PoP end (718 days ago)

Current PoP ended Sep 14, 2024 (718 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Elusys Therapeutics, Inc$123.6M obligated across 5 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$123.6M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50121C00073?

75A50121C00073 (Eo14042 LETTER contract ADD FAR 52.223-99) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $80.9M, currently held by Elusys Therapeutics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50121C00073?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50121C00073 to Elusys Therapeutics, Inc.

Who is the incumbent on 75A50121C00073?

Elusys Therapeutics, Inc is the incumbent with $123.6M across 5 related awards in SCOUT’s public footprint. The current period of performance ends Sep 14, 2024.

When does Elusys Therapeutics, Inc’s 75A50121C00073 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 14, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50121C00073 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50121C00073